Madrigal Pharmaceuticals, Inc. (MDGL)
477.60
+14.18
(+3.06%)
USD |
NASDAQ |
Feb 06, 16:00
477.25
-0.35
(-0.07%)
After-Hours: 20:00
Madrigal Pharmaceuticals SG&A Expense (TTM) : 715.08M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Eli Lilly & Co. | 11.09B |
| Crinetics Pharmaceuticals, Inc. | 165.81M |
| Insmed, Inc. | 631.20M |
| Ionis Pharmaceuticals, Inc. | 351.68M |